Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-002593

Director acquired 6,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
OLUKOTUN ADEOYE Y Director 2022-01-07 Grant or award +6,400 11,350 D: show line 1 in the form
Loading xslF345X03/doc4.xml…